From: NF-kappa B mediated Up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia
No. | Sex | Age of diagnosis (years) | Immunotype | Cytogenetic abnormality | Fusion gene | Prognosis | mRNA levels of CTCF | ||
---|---|---|---|---|---|---|---|---|---|
ND | CR | p value | |||||||
1 | M | 2 | Common B cell | - | - | Remission | 0.328 | 0.118 | Paired Samples T test: ND-CR, p = 0.000 |
2 | M | 5 | Common B cell | t(12;21) | TEL-AML1 | Remission | 0.313 | 0.098 | |
3 | M | 7 | Common B cell | t(1;19) | E2A-PBX1 | Remission | 0.275 | 0.142 | |
4 | F | 3 | Common B cell | t(12;21) | TEL-AML1 | Remission | 0.249 | 0.146 | |
5 | M | 2 | Common B cell | t(12;21) | TEL-AML1 | Remission | 0.314 | 0.124 | |
6 | F | 3 | Common B cell | t(12;21) | TEL-AML1 | Remission | 0.371 | 0.220 | |
7 | M | 4 | Common B cell | t(12;21) | TEL-AML1 | Remission | 0.327 | 0.127 | |
8 | F | 3 | Common B cell | t(12;21) | TEL-AML1 | Remission | 0.251 | 0.157 | |
9 | M | 3 | Pre-B cell | t(12;21) | TEL-AML1 | Remission | 0.195 | 0.112 | |
10 | F | 8 | Pro-B cell | - | - | Remission | 0.341 | 0.205 |